FOXP3 and graft versus host disease: Although the beneficial effects of Tregs in human GVHD were uncertain up until now, the finding that peripheral blood from patients with GVHD demonstrated reduced numbers of Foxp3+CD4+CD25+ T cells suggested the potential benefits of the clinical application of Treg cells [38], [39].